Title : Transcriptional activation of apolipoprotein CIII expression by glucose may contribute to diabetic dyslipidemia.

Pub. Date : 2011 Mar

PMID : 21183731






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Transcriptional activation of apolipoprotein CIII expression by glucose may contribute to diabetic dyslipidemia. Glucose apolipoprotein C3 Homo sapiens
2 ApoCIII induction by glucose is blunted by treatment with agonists of farnesoid X receptor and peroxisome proliferator-activated receptor-alpha but not liver X receptor, ie, nuclear receptors controlling triglyceride metabolism. Glucose apolipoprotein C3 Homo sapiens
3 Moreover, in obese humans, plasma apoCIII protein correlates more closely with plasma fasting glucose and glucose excursion after oral glucose load than with insulin. Glucose apolipoprotein C3 Homo sapiens
4 Moreover, in obese humans, plasma apoCIII protein correlates more closely with plasma fasting glucose and glucose excursion after oral glucose load than with insulin. Glucose apolipoprotein C3 Homo sapiens
5 Moreover, in obese humans, plasma apoCIII protein correlates more closely with plasma fasting glucose and glucose excursion after oral glucose load than with insulin. Glucose apolipoprotein C3 Homo sapiens
6 CONCLUSIONS: Glucose induces apoCIII transcription, which may represent a mechanism linking hyperglycemia, hypertriglyceridemia, and cardiovascular disease in type 2 diabetes. Glucose apolipoprotein C3 Homo sapiens